ISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPY

William H. Burns, George W. Santos, Rein Saral, Oscar L. Laskin, Paul S. Lietman, Colin Mclaren, David W. Barry

Research output: Contribution to journalArticle

Abstract

Sensitivity of herpes simplex virus isolates to acyclovir became reduced in two bone-marrow transplant patients treated for established mucocutaneous infections. These isolates were thymidine-kinase-deficient mutants and were isolated within a week of discontinuation of a 1 week course of acyclovir therapy. The herpetic lesions in both patients continued to heal despite continued shedding of these viruses. Further studies and experience with this new class of antiviral agents are needed to determine the extent to which emergence of less sensitive virus will present clinical difficulties and to formulate treatment regimens that will minimise the emergence of such mutants.

Original languageEnglish (US)
Pages (from-to)421-423
Number of pages3
JournalThe Lancet
Volume319
Issue number8269
DOIs
StatePublished - Feb 20 1982

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'ISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPY'. Together they form a unique fingerprint.

  • Cite this

    Burns, W. H., Santos, G. W., Saral, R., Laskin, O. L., Lietman, P. S., Mclaren, C., & Barry, D. W. (1982). ISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPY. The Lancet, 319(8269), 421-423. https://doi.org/10.1016/S0140-6736(82)91620-8